Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle claims it used speaker ...

Pharmaceutical firm Gilead has admitted paying hundreds of thousands of dollars in illegal kickbacks to US doctors between ...

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV ...

A Georgia man is facing a felony murder charge after family and prosecutors allege he knowingly did not reveal his ...

Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression ...

The Alabama Department of Public Health (ADPH) is renewing its STD/HIV At-Home Specimen Collection initiative, with kits ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

The termination of funding is part of a broader overhauling of the NIH and other U.S. government agencies under the Trump ...